Loading clinical trials...
Loading clinical trials...
Efficacy of Different Anti-Thrombotic Strategies on the Incidence of Silent Cerebral Embolism After Percutaneous Left Atrial Appendage Occlusion: a Randomized Control Trial
Conditions
Interventions
aspirin and clopidogrel
Rivaroxaban
Locations
1
China
The First Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China
Start Date
February 1, 2022
Primary Completion Date
September 1, 2024
Completion Date
September 1, 2024
Last Updated
January 4, 2023
NCT05009797
NCT06500988
NCT07421076
NCT07490808
NCT07429214
NCT05976685
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions